Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:3221-3228, 2006
DOI: 10.2337/db05-1390
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nascimento, E. B.M.
Right arrow Articles by Ouwens, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nascimento, E. B.M.
Right arrow Articles by Ouwens, D. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Insulin-Mediated Phosphorylation of the Proline-Rich Akt Substrate PRAS40 Is Impaired in Insulin Target Tissues of High-Fat Diet–Fed Rats

Emmani B.M. Nascimento1, Mariann Fodor2, Gerard C.M. van der Zon1, Ingrid M. Jazet3, A. Edo Meinders3, Peter J. Voshol4, Ronald Vlasblom5, Bart Baan1, Jürgen Eckel6, J. Antonie Maassen1,7, Michaela Diamant7, and D. Margriet Ouwens1

1 Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, the Netherlands
2 Department of Anatomy and Embryology/Central Animal Facility, Leiden University Medical Center, Leiden, the Netherlands
3 Department of General Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands
4 Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, the Netherlands
5 Laboratory for Physiology, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands
6 German Diabetes Center, Institute of Clinical Biochemistry and Pathobiochemisty, Düsseldorf, Germany
7 Department of Endocrinology, Diabetes Center, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands

Address correspondence and reprint requests to Dr. D.M. Ouwens, Department of Molecular Cell Biology, Section of Signal Transduction and Ageing, Leiden University Medical Center, Postzone S1-P, P.O. Box 9600, NL-2300 RC Leiden, Netherlands. E-mail: d.m.ouwens{at}lumc.nl

Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; ERK, extracellular signal–related kinase; GSK, glycogen synthase kinase; HFD, high-fat diet; LFD, low-fat diet; mTOR, mammalian target of rapamycin; PI3K, phosphatidylinositol 3'-kinase; PKB, protein kinase B; PRAS40, proline-rich Akt substrate 40; TBS, Tris-buffered saline

Clinical insulin resistance is associated with decreased activation of phosphatidylinositol 3'-kinase (PI3K) and its downstream substrate protein kinase B (PKB)/Akt. However, its physiological protein substrates remain poorly characterized. In the present study, the effect of in vivo insulin action on phosphorylation of the PKB/Akt substrate 40 (PRAS40) was examined. In rat and mice, insulin stimulated PRAS40-Thr246 phosphorylation in skeletal and cardiac muscle, the liver, and adipose tissue in vivo. Physiological hyperinsulinemia increased PRAS40-Thr246 phosphorylation in human skeletal muscle biopsies. In cultured cell lines, insulin-mediated PRAS40 phosphorylation was prevented by the PI3K inhibitors wortmannin and LY294002. Immunohistochemical and immunofluorescence studies showed that phosphorylated PRAS40 is predominantly localized to the nucleus. Finally, in rats fed a high-fat diet (HFD), phosphorylation of PRAS40 was markedly reduced compared with low-fat diet–fed animals in all tissues examined. In conclusion, the current study identifies PRAS40 as a physiological target of in vivo insulin action. Phosphorylation of PRAS40 is increased by insulin in human, rat, and mouse insulin target tissues. In rats, this response is reduced under conditions of HFD-induced insulin resistance.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
H. P.M. M. Lauritzen, T. Ploug, H. Ai, M. Donsmark, C. Prats, and H. Galbo
Denervation and High-Fat Diet Reduce Insulin Signaling in T-Tubules in Skeletal Muscle of Living Mice
Diabetes, January 1, 2008; 57(1): 13 - 23.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Alkhateeb, A. Chabowski, J. F. C. Glatz, J. F. P. Luiken, and A. Bonen
Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E783 - E793.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Oshiro, R. Takahashi, K.-i. Yoshino, K. Tanimura, A. Nakashima, S. Eguchi, T. Miyamoto, K. Hara, K. Takehana, J. Avruch, et al.
The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1
J. Biol. Chem., July 13, 2007; 282(28): 20329 - 20339.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.